'%20/%3e%3c!--%20Center%20the%20hexagon%20by%20shifting%20it%20by%20300,%20300%20--%3e%3cg%20transform='translate(300,%20300)%20scale(0.82)'%3e%3cpolygon%20points='0,-240%20207.85,-120%20207.85,120%200,240%20-207.85,120%20-207.85,-120'%20fill='none'%20stroke='rgba(255,255,255,0.8)'%20stroke-width='12'%20stroke-linejoin='round'/%3e%3cline%20x1='0'%20y1='-240'%20x2='0'%20y2='0'%20stroke='%2338bdf8'%20stroke-width='10'%20stroke-linecap='round'/%3e%3cline%20x1='-207.85'%20y1='120'%20x2='0'%20y2='0'%20stroke='%2338bdf8'%20stroke-width='10'%20stroke-linecap='round'/%3e%3cline%20x1='207.85'%20y1='120'%20x2='0'%20y2='0'%20stroke='%2338bdf8'%20stroke-width='10'%20stroke-linecap='round'/%3e%3ccircle%20cx='0'%20cy='-240'%20r='22'%20fill='%2360a5fa'/%3e%3ccircle%20cx='207.85'%20cy='120'%20r='22'%20fill='%2360a5fa'/%3e%3ccircle%20cx='-207.85'%20cy='120'%20r='22'%20fill='%2360a5fa'/%3e%3ccircle%20cx='0'%20cy='0'%20r='38'%20fill='none'%20stroke='rgba(255,255,255,0.9)'%20stroke-width='20'/%3e%3ccircle%20cx='0'%20cy='0'%20r='16'%20fill='white'/%3e%3ccircle%20cx='0'%20cy='0'%20r='90'%20fill='none'%20stroke='%2338BDF8'%20stroke-width='8'%20stroke-dasharray='24%2016'%20opacity='0.6'/%3e%3c/g%3e%3c/svg%3e)
How Solaris Endovascular Is Using AI to Reinvent Investor Due Diligence?
Over 60% of MedTech funding delays stem from inefficient documentation workflows. Solaris Endovascular is changing that with AI.
Healthcare Innovator,
Even when the clinical science is strong, investor due diligence remains one of the slowest, most fragmented steps in commercialization. Solaris Endovascular, a pioneer in vascular stent technologies, decided to change that by partnering with Clinical.enclavia.ai to automate and accelerate the investor due diligence process.
The Goal
To transform the traditional diligence cycle into a 4-6 week, AI-verified process that produces evidence-backed reports, automated risk summaries, and investor-ready documentation directly from the company's data room.
How the Due Diligence Engine Works
- Ingests and organizes the entire Solaris data room
- Automates 176+ due diligence questions
- Auto-generates a 30-40 page Due Diligence Report
- Drafts a Private Placement Memorandum (PPM)
By connecting every data point from clinical results to financials, Clinical.enclavia.ai transforms due diligence from a bottleneck into a competitive advantage.
Dev Roy
CEO, Enclavia
Written by Enclavia Research Team
Research Division
Advancing the frontier of predictive clinical intelligence and sovereign data architecture.
Share
Ready to scale?
Get a demo of our high-scale retrieval engine.